Perspective Therapeutics, Inc. · AMEX:CATX
Commodore Capital LP reported a 5.50% stake in Perspective Therapeutics, Inc. (Schedule 13G/A)
Event Sep 30, 2026 · Filed Nov 16, 2026
Commodore Capital LP reported a 5.50% stake in Perspective Therapeutics, Inc., 6,598,046 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G/A).
- Stake
- 5.50%
- Shares
- 6,598,046
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Commodore Capital LP | 5.50% | 6,598,046 |
| Commodore Capital Master LP | 5.50% | 6,598,046 |
| Robert Egen Atkinson | 5.50% | 6,598,046 |
| Michael Kramarz | 5.50% | 6,598,046 |
Source
Download original · View original at SEC
Related
- Perspective Therapeutics, Inc.
- Commodore Capital LP
- Perspective Therapeutics, Inc. shareholders
- Schedule 13G · Commodore Capital LP · Feb 9, 2026
- Schedule 13D/A · Lantheus Holdings, Inc. · Nov 12, 2026
- Schedule 13G · State Street Corp · Nov 10, 2026
- Schedule 13D/A · Lantheus Holdings, Inc. · Sep 23, 2026
- Form 4 · Lantheus Alpha Therapy, LLC · Sep 8, 2026
- Form 4 · Lantheus Holdings, Inc. · Sep 4, 2026